Holen Sie sich die Stockscreener-App
1.40
0.00%
0.00
Handel nachbörslich:
1.34
-0.06
-4.29%
Schlusskurs vom Vortag:
$1.40
Offen:
$1.4
24-Stunden-Volumen:
198.03K
Relative Volume:
0.39
Marktkapitalisierung:
$62.82M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-1.3462
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+6.87%
1M Leistung:
+17.65%
6M Leistung:
+2.94%
1J Leistung:
-48.91%
1-Tages-Spanne:
$1.33
$1.4278
1-Wochen-Bereich:
$1.25
$1.50
52-Wochen-Spanne:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.40 | 58.78M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
What analysts say about Werewolf Therapeutics Inc. stockHigh-velocity gains - jammulinksnews.com
How Werewolf Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser
What drives Werewolf Therapeutics Inc. stock priceFree Capital Growth Strategies - jammulinksnews.com
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Shares - Newser
Is Werewolf Therapeutics Inc. a good long term investmentConsistently exceptional gains - Autocar Professional
Werewolf Therapeutics Inc. Stock Analysis and ForecastHigh-octane financial growth - jammulinksnews.com
What makes Werewolf Therapeutics Inc. stock price move sharplyInvestor Favorite Picks - Newser
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - MSN
Vontobel Holding Ltd. Acquires New Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics to Present Innovative IL-2 INDUKINE Development at KidneyCAN 7th Annual Kidney Cancer Research Summit - Nasdaq
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit - GlobeNewswire
Werewolf Therapeutics: A High-Risk, High-Potential Bet in Cancer Immunotherapy - criticalcontrolroomworld.com
Werewolf Therapeutics (NASDAQ:HOWL) Trading Up 1% – What’s Next? - Defense World
Werewolf Therapeutics Adopts New Bylaws and Elects Directors - TipRanks
Two Sigma Investments LP Sells 87,168 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewswire
Jane Street Group LLC Acquires 39,564 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Two Sigma Advisers LP Sells 117,200 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shares Sold by Millennium Management LLC - Defense World
Deutsche Bank AG Buys 83,172 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Northern Trust Corp Acquires 16,640 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Bank of America Corp DE Lowers Stock Position in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics Announces Q1 2025 Financial Results - MSN
Werewolf Therapeutics Leaders to Reveal Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan
Werewolf Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference on June 5, 2025 - Nasdaq
Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference - GlobeNewswire
D. E. Shaw & Co. Inc. Makes New Investment in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics (HOWL) Price Target Lowered by BofA, Buy Rating Maintained | HOWL Stock News - GuruFocus
Werewolf Therapeutics (HOWL) Price Target Lowered by BofA, Buy R - GuruFocus
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):